• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Pharmaceutical Pleuromulin Raw material powder

    • Pharmaceutical Pleuromulin Raw material powder
    • Pharmaceutical Pleuromulin Raw material powder storehouse
    • Pharmaceutical Pleuromulin Raw material powder quality testing
    • Pharmaceutical Pleuromulin Raw material powder quality testing
    • Pharmaceutical Pleuromulin Raw material powder certificate

    Product Overview:

    The discovery of truncated laterin drugs was in the 1970s, and in 1978 the first drug listed by the Swiss company Novartis - Tymycin, mainly used to treat diarrhea, pneumonia and other related diseases in pigs. Up to now, four drugs of truncated pleurin have been developed: tymycin, vonimulin, azamoline and ratapaline. Taimycin and warnemyline are relatively toxic, and they are only used as animal-specific drugs at present, and Taimycin is the most effective and most effective. Azamoline and Retapaline were later developed for human use, but azamoline was shelved due to water solubility and bioavailability issues, and Retapaline is currently used in human medicine only.

    Pharmaceutical Pleuromulin Raw material powder Attributes

    Pleuromulin Raw material powder

    CAS:125-65-5

    MF:C22H34O5

    Pleuromulin

    MW:378.5

    EINECS:204-747-5

    Specification: 99% min Pleuromulin powder

    Sample:Pleuromulin powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance:white

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Pharmaceutical Pleuromulin Raw material powder Details

    Pleuromulin Powder Usage and Synthesis.

    Pleurin truncatus is a broad-spectrum diterpene antibiotic produced by Pleurus. It can inhibit the protein synthesis of bacteria, thus achieving the effect of inhibiting bacterial growth. It works in a different way than other types of antibiotics. In the mechanism of action. Truncated pleurotins mainly act on the ribosome level of bacterial cells, and inhibit the synthesis of bacterial proteins by inhibiting the activity of peptidyl transferase, so as to achieve a broad spectrum antibacterial effect. The main skeleton of truncated pleurotins is composed of three rings, and the basic structure of the group is eight membered rings. The carbonyl group on the five-membered ring and the hydroxyl group on C-11 are the necessary groups for activity, and most foreign studies are to chemically modify C-14, so as to greatly improve its antibacterial activity and bioavailability. Because C-14 of the truncated pleurin drugs contains free hydroxyl groups, it is not active; By modifying C-14, the derivatives with enhanced antibacterial activity against bacteria and mycoplasma can be obtained.

    Pleuromulin powder

    Uses of Pleuromulin.

    Pleulopleutin is a new type of hearing repair treatment that can help those who have lost their hearing due to deafness regain the ability to hear. For many deaf people, this was a major innovation that brought hope and change.

    Pleuromulin

    Pharmacological action of Pleuromulin.

    Product Method of Bulk Pleuromulin Powder.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,